Aripiprazole-induced Tardive Dyskinesia in 13 Years Old Girl Successfully Treated with Biperiden: A Case Report
Open Access
- 31 August 2017
- journal article
- Published by Korean College of Neuropsychopharmacology in Clinical Psychopharmacology and Neuroscience
- Vol. 15 (3), 285-287
- https://doi.org/10.9758/cpn.2017.15.3.285
Abstract
In the last years second-generation antipsychotics are increasingly prescribed in the pediatric population for the treatment of several psychiatric disorders. Among the long term adverse effects, extrapyramidal symptoms (EPS) are less reported compared to first-generation antipsychotics. Tardive dyskinesia (TD) is a iatrogenic rare syndrome characterized by persistent slow writhing and sudden involuntary movements mainly involving the oral-buccal-lingual area with masticatory movements. We report a young girl with mood disorders accompanied by mild intellectual disability and behavioral problems who had TD after treatment with Aripiprazole, which responded to Biperiden therapy.Keywords
This publication has 23 references indexed in Scilit:
- Aripiprazole: from pharmacological profile to clinical useNeuropsychiatric Disease and Treatment, 2015
- A Case of Aripiprazole Induced Tardive Dyskinesia in a Neuroleptic-Naïve Patient with Two Years of Follow UpClinical Psychopharmacology and Neuroscience, 2014
- Incidence of Extrapyramidal Syndromes and Tardive DyskinesiaJournal of Clinical Psychopharmacology, 2011
- Tardive DyskinesiaCurrent Treatment Options in Neurology, 2011
- Incidence of Extrapyramidal Symptoms and Tardive Dyskinesia in SchizophreniaJournal of Clinical Psychopharmacology, 2010
- Tardive dystonic symptoms associated with aripiprazole treatmentProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2008
- Aripiprazole (abilify) and tardive dyskinesia.2008
- Tardive Dyskinesia in the Era of Typical and Atypical Antipsychotics. Part 2: Incidence and Management Strategies in Patients with SchizophreniaThe Canadian Journal of Psychiatry, 2005
- Lower Risk for Tardive Dyskinesia Associated With Second-Generation Antipsychotics: A Systematic Review of 1-Year StudiesAmerican Journal of Psychiatry, 2004
- Aripiprazole, A Novel Atypical Antipsychotic Drug with a Unique and Robust PharmacologyNeuropsychopharmacology, 2003